XML 340 R108.htm IDEA: XBRL DOCUMENT v3.23.1
Business Segments (Information on Operating and Reportable Segments) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Feb. 28, 2023
Feb. 28, 2022
Feb. 28, 2021
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Segment Reporting Information, Profit (Loss):            
Total segment revenues       $ 1,127,725 $ 1,086,812 $ 943,365
Cost of sales       502,431 466,166 395,893
Gross profit       625,294 620,646 547,472
Advertising and marketing       145,061 157,343 140,589
Contribution margin       480,233 463,303 406,883
Other operating expenses       502,648 133,384 109,481
Operating (loss) income       (22,415) 329,919 297,402
Impairment of intangible assets   $ 700   321,412 1,700  
Impairment loss       (48,805) (340)  
North American OTC Healthcare            
Segment Reporting Information, Profit (Loss):            
Total segment revenues       973,774 967,881 849,319
Cost of sales       441,844 419,162 359,100
Gross profit       531,930 548,719 490,219
Advertising and marketing       123,926 138,714 122,857
Contribution margin       408,004 410,005 367,362
Impairment loss $ (48,800)     (48,805) 0  
North American OTC Healthcare | Intersegment Eliminations            
Segment Reporting Information, Profit (Loss):            
Total segment revenues       4,300 3,000 3,200
International OTC Healthcare            
Segment Reporting Information, Profit (Loss):            
Total segment revenues       153,951 118,931 94,046
Cost of sales       60,587 47,004 36,793
Gross profit       93,364 71,927 57,253
Advertising and marketing       21,135 18,629 17,732
Contribution margin       72,229 53,298 $ 39,521
Impairment loss   $ (300) $ (1,200) $ 0 $ (340)